Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Feldan Therapeutics

Request full access

Feldan Therapeutics has developed a patented peptide-based technology platform

Quebec City, CanadaFounded 2007Biotech & Life Sciences

About Feldan Therapeutics

Feldan Therapeutics is a biopharmaceutical company focused on developing breakthrough treatments that work within cells. The company operates in the healthcare and biotechnology market, targeting medical professionals and institutions that require advanced therapeutic solutions. Feldan's core product is the Feldan Shuttle, a unique peptide-based technology that allows for the intracellular delivery of therapeutics, reaching targets that existing drugs cannot. This innovative approach aims to improve the quality of life by addressing unmet medical needs. Feldan generates revenue through the development and commercialization of its proprietary technologies and therapeutic solutions, partnering with other biotech firms and healthcare providers to bring its products to market.

Source: Dealroom company data

At a glance

Status
Operational
Employees
48
Open positions
None listed
Dealroom signal
82.0/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

8 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing Apr 2025 $0 — Zynext Ventures ↗
LATE VCOther financing Feb 2025 $0 — Invest Quebec · Fonds de solidarité FTQ · Amgen Ventures · Genesys Capital ↗
Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Growth signals

Feldan Therapeutics website traffic

Latest recorded traffic for Feldan Therapeutics is 2.3K monthly website visits, up 164.4% over the last three months. Feldan Therapeutics's team grew 14.3% over the past year.

Latest monthly visits2.3K 3-month web change+164.4% 1-year team growth+14.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Feldan Therapeutics in the Quebec City ecosystem

Live from Dealroom

The Feldan Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

15 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

  • Anges Quebec
  • FIER Succes
  • Cystic Fibrosis Foundation

Series A9 investors entered at this stage

  • AQC Capital
  • Stonebridge Ventures
  • Invest Quebec
  • GC LabCell
  • FSITII
  • Amgen Ventures
  • GC Pharma
  • Fonds de solidarité FTQ
  • Genesys Capital

Series B and later2 investors entered at this stage

  • Linear Capital
  • Zynext Ventures

Other known investors1 additional known investor

  • Laval University
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇨🇦 Canada90%
🇺🇸 United States7.5%
🇫🇷 France2.5%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Feldan Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Feldan Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.